Without insurance coverage for GLP-1 medications, known by brand names Fundayo, Ozempic, Wegovy, Mounjaro, or Zepbound, individuals could spend anywhere from $900 to $1,300 a month
ceramide-rich creams and ointments work better than lotions for GLP-1 patients losing weight rapidly
Restrictions, product changes, and supply issues will make margins swing and disrupt patient care
On low-appetite days, the task of cooking can feel insurmountable
Finally, we introduce the potential of L-cell differentiation as an attractive future therapeutic approach to increase GLP-1 production as an attractive therapeutic alternative for T2DM
European Atherosclerosis Society National Lipid Association To view or add a comment, sign in Researchers found that follistatin (FST) protects against atherosclerosis by increasing fat burning, improving mitochondrial function, reducing inflammation, stabilizing arterial plaques, and enhancing lipid metabolism, making it a promising therapeutic target for cardiovascular disease
